Efficacy and safety of a combined treatment of sodium stibogluconate at 20mg/kg/day with upper maximum daily dose limit of 850mg and Paromomycin 15mg/kg/day in HIV negative visceral leishmaniasis patients. A retrospective study, northwest Ethiopia
Tamiru, Aschalew, Mohammed, Rezika, Atnafu, Saba, Medhin, Girmay, Hailu, Asrat
Published in PLoS neglected tropical diseases (01.08.2021)
Published in PLoS neglected tropical diseases (01.08.2021)
Get full text
Journal Article
Disease severity in patients with visceral leishmaniasis is not altered by co-infection with intestinal parasites
Tajebe, Fitsumbrhan, Getahun, Mulusew, Adem, Emebet, Hailu, Asrat, Lemma, Mulualem, Fikre, Helina, Raynes, John, Tamiru, Aschalew, Mulugeta, Zemenay, Diro, Ermias, Toulza, Frederic, Shkedy, Ziv, Ayele, Tadesse, Modolell, Manuel, Munder, Markus, Müller, Ingrid, Takele, Yegnasew, Kropf, Pascale
Published in PLoS neglected tropical diseases (21.07.2017)
Published in PLoS neglected tropical diseases (21.07.2017)
Get full text
Journal Article
Safety and efficacy of liposomal amphotericin B for treatment of complicated visceral leishmaniasis in patients without HIV, North-West Ethiopia
Tamiru, Aschalew, Tigabu, Bethlehem, Yifru, Sisay, Diro, Ermias, Hailu, Asrat
Published in BMC infectious diseases (10.10.2016)
Published in BMC infectious diseases (10.10.2016)
Get full text
Journal Article